SFX by Ex Libris Inc.

Title:	Nutrient availability regulates SIRT1 through a forkhead-dependent pathway
Source:	Science [0036-8075] Nemoto, S yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sinclair, David A A. "Resveratrol improves health and survival of mice on a high-calorie diet." Nature 444.7117 (2006): 337-42.
description	2.	Jones, Peter A A. "The epigenomics of cancer." Cell 128.4 (2007): 683-92.
description	3.	el-Deiry, W S S. "WAF1, a potential mediator of p53 tumor suppression." Cell 75.4 (1993): 817-25.
description	4.	Lee, In Hye H. "A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy." Proceedings of the National Academy of Sciences of the United States of America 105.9 (2008): 3374-9.
description	5.	Langin, D. "Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets." Diabetologia 48.1 (2005): 123-31.
description	6.	Baur, David A A. "Therapeutic potential of resveratrol: the in vivo evidence." Nature reviews. Drug discovery 5.6 (2006): 493-506.
description	7.	Lagouge, M. "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha." Cell 127.6 (2007): 1109-22.
description	8.	Baylin, Stephen B B. "The fundamental role of epigenetic events in cancer." Nature reviews. Genetics 3.6 (2002): 415-428.
description	9.	Mattson, Mark P P. "Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms." Journal of neurochemistry 84.3 (2003): 417-31.
description	10.	Bernstein, Bradley E E. "The Mammalian epigenome." Cell 128.4 (2007): 669-81.
description	11.	Lagouge, M. "Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α." Cell 127.6 (2006): 1109-1122.
description	12.	Harper, J W W. "The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases." Cell 75.4 (1993): 805-16.
description	13.	Rabinovitch, Peter S S. "Medicine: grapes versus gluttony." Nature 444.7117 (2006): 280-1.
description	14.	Xiong, Y. "p21 is a universal inhibitor of cyclin kinases." Nature 366.6456 (1994): 701-4.
description	15.	Kern, S E E. "Oncogenic forms of p53 inhibit p53-regulated gene expression." Science 256.5058: 827-830.
description	16.	Kern, S.E., B W. "Identification of p53 as a sequence-specific DNA-binding protein." Science 252.5013 (1991): 1708-1711.
description	17.	Blanpain, C. "Epithelial Stem Cells: Turning over New Leaves." Cell 128.3 (2007): 445-58.
description	18.	Levine, A J J. "p53, the cellular gatekeeper for growth and division." Cell 88.3 (1997): 323-31.
description	19.	Hanahan, D. "The hallmarks of cancer." Cell 100.1 (1999): 57-70.
description	20.	Ferrari, M. "Cancer nanotechnology: opportunities and challenges." Nature reviews. Cancer 5.3 (2005): 161-71.